---
$id: https://graph.org.ai/products/commodity/51162618
$type: Product
source: UNSPSC
code: "51162618"
title: "Cloperastine fendizoate"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cloperastine fendizoate

**UNSPSC Code**: 51162618
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent C20H24ClNO.C20H14O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2M105305SU, chemically known as benzoic acid, 2-((6-hydroxy(1,1'-biphenyl)-3-yl)carbonyl)-, compd. with 1-(2-((4-chlorophenyl)phenylmethoxy)ethyl)piperidine (1:1), but more generally known as cloperastine fendizoate, which bears US NIH Compound Identifier 163446. European Medicines Agency schedules Cloperastine fendizoate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01366MIG. Most nations, for tariff and trade purposes, schedule cloperastine fendizoate under HS 29333999 and SITC 51574. As of Q4 2014, CLOPERASTINE FENDIZOATE remains US FDA's Preferred Term for this commodity. Cloperastine fendizoate bears US NLM identifiers UMLS ID C2987012 and NCI Concept Code C95234. SMILES: C1CCC(CC1)C2C(CCCC2O)C(=O)C3CCCCC3C(=O)O.C1CCC(CC1)C(C2CCC(CC2)CL)OCCN3CCCCC3.

